Potassium Citrate - Delayed Release
Process , Technology, Applications, Patent, Plant, Company Profiles, Reports, Market, Projects, Raw Material

Primary Information Services
Home . Pharmaceutical Industry .Ordering Information . Contact

Information @ a Glance

Contents on the CD Rom

  • Oral extended release drug delivery medication will continue to account for the largest share of drug delivery systems. The extended release product will optimize therapeutic effect and safety of a drug at the same time improving the patient convenience and compliance.
  • Extended release products have many advantages
  • Matrix system is widely used for the
    purpose of sustained release
  • The matrix system can be divided into two categories depending on the types of retarding agents or polymeric materials.
    1) Hydrophobic matrix system
    2) Hydrophilic matrix system
    3) Fat-wax matrix system
  • Unlike reservoir and osmotic systems, products based on matrix design can be manufactured using conventional processes and equipments
  • Potassium citrate Extended-Release Tablets, is an oral preparation of
    potassium citrate which is imbedded in wax matrix to insure slow release. The main
    physiological response to potassium citrate treatment is a rise in urinary citrate and urinary pH, largely a consequence of the alkali load, rather than the appearance in urine of administered citrate.

Basic Information

  • Extended Release Matrix Technology
  • Extended release drug delivery Technology
  • Product Profile

Products Information

  • Prescribing Information
  • Wax Matrix Tablets
  • Product details
  • Product Monograph
  • Product Specification
  • Full prescription data
  • Three Potassium Citrate - 1  Hydrates PRS
  • Three-potassium citrate 1-hydrate
  • Potassium citrate monohydrate
  • Potassium Citrate
  • Chewable Tablets
  • Potassium Citrate - food additive
  • Potassium Citrate
  • Certificate of analysis

Raw Material Suppliers

  • Potassium Citrate suppliers
  • Pharma Grade raw materials
  • Ingredient supplier


  • Company in Patent dispute
  • Controlled release dosage form

Company Performances

  • Major Player
  • Company - Financial performance
  • Company presentation
  • Consultant's Report

Technology Information

  • Guidance on Potassium Citrate
  • Research support
  • Preparing controlled release tablets
  • Carnauba wax as a carrier for aroma encapsulation
  • Wax-lipid based materials
  • Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant
  • Release Process for a Reservoir Device Tablet
  • Design & Evaluation Prolonged Release - case study

Market Scenario

  • Generic Drug Marketplace
  • International Trade commission report
  • Application
  • News - Controlled release alliance
  • Marketing Information
  • Drug List - 2013
  • Historical Data

Order the CD ROM Today

Primary Information Services
 21 Murugappan St, SwamyNagar Ext2, 
Ullagaram, Chennai - 600091, India.
 Phone: 91 44 22421080 
Email : informer@eth.net
Mobile numbers:9940043898, 9444008898  Fax : 91 44 22423753